Home › Funds › TOWLE & CO › ASTH
TOWLE & CO position in ASTH
ASTRANA HEALTH INC · Consumer Discretionary
TOWLE & CO reported holding 122,801 shares of ASTH (ASTRANA HEALTH INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 1.49% of its reported portfolio and ranking #34 among its reported holdings. TOWLE & CO has disclosed ASTH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How TOWLE & CO's ASTH position evolved
TOWLE & CO first disclosed a stake in ASTH in Q2 2026 at 122,863 shares (US$5.7M). Across 2 filings, TOWLE & CO held the position steady without any share-count change. The most recent filing (Q3 2026) shows 122,801 shares valued at US$4.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 122.86K | $5.70M | New |
| Q3 2026 | 122.80K | $4.37M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ASTH and 13F data
ASTH (ASTRANA HEALTH INC) is a Consumer Discretionary company. 41 other funds we track also report a position in ASTH — the largest reported positions include 325 CAPITAL LLC (US$74.9M), SteelPeak Wealth, LLC (US$15.5M), 683 Capital Management, LLC (US$9.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ASTH
- 325 CAPITAL LLC 1.61M sh · $74.90M · Q2 2026
- SteelPeak Wealth, LLC 435.14K sh · $15.48M · Q3 2026
- 683 Capital Management, LLC 210.00K sh · $9.75M · Q2 2026
More on TOWLE & CO
FAQ
How long has TOWLE & CO held ASTH?
TOWLE & CO has disclosed ASTH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is TOWLE & CO's current position in ASTH?
As of Q3 2026, TOWLE & CO holds 122.80K shares of ASTH (ASTRANA HEALTH INC), valued at $4.37M, representing 1.49% of its reported portfolio and ranking #34.
Has TOWLE & CO been buying or selling ASTH?
In the latest 13F filing (Q3 2026), TOWLE & CO held unchanged its position in ASTH.
Which other funds hold ASTH?
Other major institutional holders of ASTH include 325 CAPITAL LLC, SteelPeak Wealth, LLC, 683 Capital Management, LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.